Author

Alexandra Papadimou

Observed name: A Papadimou

Institution: National and Kapodistrian University of Athens

Observed institutions: National and Kapodistrian University of Athens, Alexandra Hospital

ORCID: 0009-0009-3659-0149

Observed ORCID: 0009-0009-3659-0149

OpenAlex ID: A5050304748

Single‐cell analysis of MYD88L265P and MYD88WT Waldenström macroglobulinemia patients

2024 · Tina Bagratuni, Foteini Aktypi, et al. · HemaSphere · 9

PDF

Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia

2025 · Tina Bagratuni, Ourania Theologi, et al. · Blood · 7

Highly Sensitive Detection Method of CXCR4 Tumor Hotspot Mutations by Drop-Off Droplet Digital PCR in Patients with IgM Monoclonal Gammopathies

2023 · Athina N. Markou, Tina Bagratuni, et al. · Journal of Molecular Diagnostics · 5

PDF

MYD88 Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges

2023 · Tina Bagratuni, Alexandra Papadimou, et al. · Hemato · 3

PDF

Circulating tumor cells by Next Generation Flow Cytometry as a new prognostic biomarker for patients with asymptomatic monoclonal gammopathies

2025 · Efstathios Kastritis, Panagiotis Malandrakis, et al. · Blood Cancer Journal · 2

PDF

Circulating Tumor Cells By Next Generation Flow Cytometry May be a New Prognostic Biomarkers Among Patients with Asymptomatic Monoclonal Gammopathies

2024 · Panagiotis Malandrakis, Ioannis V Kostopoulos, et al. · Blood · 2

Circulating Tumor Cells By Next Generation Flow Cytometry May be a New Prognostic Biomarkers Among Patients with Asymptomatic Monoclonal Gammopathies

2023 · Efstathios Kastritis, Panagiotis Malandrakis, et al. · Blood · 1

PDF

OA-18 Distinct Immune and Genomic Signatures Predict Resistance to Ibrutinib Therapy in Waldenström Macroglobulinemia

2026 · Tina Bagratuni, Christos Vlachos, et al. · Clinical Lymphoma Myeloma & Leukemia

PA-014 A Scoring Model Based on 3D Telomere Profiling of Circulating Tumor Cells in the Peripheral Blood Predicts Relapse in Newly Diagnosed Multiple Myeloma Patients

2026 · Yulia Shifrin, Zahabiya Husain, et al. · Clinical Lymphoma Myeloma & Leukemia

PA-527 Whole Genome Sequencing of Circulating Multiple Myeloma Cells with a Novel Clinical Assay Enables Identification of Genetic Alterations Underlying Immunotherapy Resistance

2026 · Bruno Paiva, Peter M. Voorhees, et al. · Clinical Lymphoma Myeloma & Leukemia

PA-083 Circulating Tumor Cells and Plasma MYD88 Mutation Allele Fraction as Prognostic Markers for Staging and Ibrutinib Response in Waldenström Macroglobulinemia

2026 · Tina Bagratuni, Ioannis Kollias, et al. · Clinical Lymphoma Myeloma & Leukemia

PA-375 Proteogenomic Integration Reveals Predictive Signatures of Ibrutinib Response in Waldenström Macroglobulinemia

2026 · Christos Vlachos, Ioannis Kollias, et al. · Clinical Lymphoma Myeloma & Leukemia

Prognostic value of MYD88 / CXCR4 mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay

2026 · Eleni Thanou, Ioannis Kollias, et al. · HemaSphere

Abstract 1067: Whole genome sequencing of multiple myeloma genomes with a novel clinical assay enables identification of genetic alterations underlying immunotherapy resistance

2026 · Bruno Paiva, Peter Voorhees, et al. · Cancer Research

Distinct immune and genomic signatures predict resistance to ibrutinib therapy in Waldenström macroglobulinemia

2026 · Tina Bagratuni, Christos Vlachos, et al. · Research Square

On a quest for fingerprints of crystalglobulinemia on platelets and endothelium

2025 · Vasiliki Gkalea, Panagiota-Efstathia Nikolaou, et al. · Blood Vessels Thrombosis & Hemostasis

Comprehensive characterization of multiple myeloma genomes from bone marrow or peripheral blood with a novel clinical assay enables identification of resistance mechanisms

2025 · Bruno Paiva, Patricia Greipp, et al. · Blood

PDF

Integrated transcriptomic and proteomic analysis of clonal plasma cells from patients with AL amyloidosis

2025 · Ourania Theologi, Ioannis Kollias, et al. · Blood

PDF

Plasma proteomic analysis as a tool for monitoring the development of ibrutinib resistance in Waldenström macroglobulinemia.

2025 · Tina Bagratuni, Ioannis Kollias, et al. · Blood

PDF

Von willebrand factor levels show independent prognostic significance in patients with AL amyloidosis treated with daratumumab-based therapies

2025 · Foteini Theodorakakou, Zoey Kapsimali, et al. · Blood

PDF

Single Cell RNA and Whole Genome Sequencing Analysis Reveal Distinct Immune and Genomic Signatures in WM Patients Resistant to Ibrutinib Therapy

2025 · Tina Bagratuni, Christos Vlachos, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: MM-434 Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies

2025 · Konstantinos Giannakas, Panagiotis Malandrakis, et al. · Clinical Lymphoma Myeloma & Leukemia

MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies

2025 · Konstantinos Giannakas, Panagiotis Malandrakis, et al. · Clinical Lymphoma Myeloma & Leukemia

The Combined Treatment of Btkis with Venetoclax Exhibits an Enhanced Therapeutic Effect on Waldenström Macroglobulinemia Cells Bearing CXCR4 Mutations

2024 · Eleni Kalafati, Kostantina Taouxi, et al. · Blood

PDF

Genomic Characterization of Ibrutinib-Resistant Waldenström's Macroglobulinemia

2024 · Tina Bagratuni, Christos Vlachos, et al. · Blood

PDF

Works count: 31

Citation count: 29

H-index: 3

I10-index: